John D. Weinberg
Keine laufenden Positionen mehr
Karriereverlauf von John D. Weinberg
Ehemalige bekannte Positionen von John D. Weinberg
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MAAT PHARMA | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2020 | 01.06.2022 |
| VELOXIS PHARMACEUTICALS A/S | Geschäftsführer | 01.07.2010 | 29.02.2016 |
| Public Communications Contact | 02.06.2011 | 29.02.2016 | |
| Corporate Officer/Principal | 24.05.2012 | 07.06.2013 | |
| ENZON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2005 | 01.01.2005 |
| 4D PHARMA PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2017 | - |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - | - |
Ausbildung von John D. Weinberg
| University of the Witwatersrand | Doctorate Degree |
| INSEAD | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 3 |
| Frankreich | 3 |
| Dänemark | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Chief Operating Officer | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ENZON PHARMACEUTICALS, INC. | Health Technology |
| 4D PHARMA PLC | Health Technology |
| MAAT PHARMA | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
- Börse
- Insiders
- John D. Weinberg
- Erfahrung
